AU705533B2 - Nitrosylated neuropeptides - Google Patents

Nitrosylated neuropeptides Download PDF

Info

Publication number
AU705533B2
AU705533B2 AU54469/96A AU5446996A AU705533B2 AU 705533 B2 AU705533 B2 AU 705533B2 AU 54469/96 A AU54469/96 A AU 54469/96A AU 5446996 A AU5446996 A AU 5446996A AU 705533 B2 AU705533 B2 AU 705533B2
Authority
AU
Australia
Prior art keywords
smooth muscle
treatment
compound
composition
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU54469/96A
Other languages
English (en)
Other versions
AU5446996A (en
Inventor
Inigo Saenz De Tejada
Jonathan Stamler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston University
Brigham and Womens Hospital Inc
Original Assignee
Boston University
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston University, Brigham and Womens Hospital Inc filed Critical Boston University
Publication of AU5446996A publication Critical patent/AU5446996A/en
Application granted granted Critical
Publication of AU705533B2 publication Critical patent/AU705533B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU54469/96A 1995-04-21 1996-04-10 Nitrosylated neuropeptides Ceased AU705533B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/426,935 US5612314A (en) 1995-04-21 1995-04-21 Nitrosylated neuropeptides
US08/426935 1995-04-21
PCT/US1996/004850 WO1996032954A1 (en) 1995-04-21 1996-04-10 Nitrosylated neuropeptides

Publications (2)

Publication Number Publication Date
AU5446996A AU5446996A (en) 1996-11-07
AU705533B2 true AU705533B2 (en) 1999-05-27

Family

ID=23692802

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54469/96A Ceased AU705533B2 (en) 1995-04-21 1996-04-10 Nitrosylated neuropeptides

Country Status (7)

Country Link
US (1) US5612314A (enExample)
EP (1) EP0822826B1 (enExample)
JP (1) JP3915125B2 (enExample)
AU (1) AU705533B2 (enExample)
CA (1) CA2218616C (enExample)
DE (1) DE69615171D1 (enExample)
WO (1) WO1996032954A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994294A (en) * 1996-02-02 1999-11-30 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US5910482A (en) * 1996-03-19 1999-06-08 Board Of Regents, The University Of Texas System Treatment or prevention of preeclampsia, eclampsia with calcitonin gene related peptide, CGRP analog, progestational agent, nitric oxide source, and cyclooxygenase inhibitor
AU731349B2 (en) * 1996-12-02 2001-03-29 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating sexual dysfunctions
WO1998052580A1 (en) * 1997-05-21 1998-11-26 Duke University Treating asthma by preventing and/or accommodating for s-nitrosothiol breakdown
AU742787B2 (en) 1997-07-09 2002-01-10 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6103765A (en) * 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US20020099003A1 (en) * 1997-10-28 2002-07-25 Wilson Leland F. Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof
US6207855B1 (en) 1998-06-23 2001-03-27 Duke University Medical Center Stable no-delivering compounds
US20050020547A1 (en) * 1999-11-08 2005-01-27 Pfizer Inc. Compounds for the treatment of female sexual dysfunction
IL139457A0 (en) 1999-11-08 2001-11-25 Pfizer Compounds for the treatment of female sexual dysfunction
US6417347B1 (en) * 2000-08-24 2002-07-09 Scimed Life Systems, Inc. High yield S-nitrosylation process
EP1427323A4 (en) * 2001-08-20 2004-09-15 Univ Virginia USE OF S-NITROSOTHIOL SIGNALING TO TREAT BREATH CONTROL DISORDERS
WO2003061680A2 (en) * 2002-01-26 2003-07-31 Mondobiotech Laboratories Anstalt Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of chronic obstructive pulmonary disease
WO2004091649A1 (en) * 2003-04-14 2004-10-28 Immuneregen Biosciences, Inc. Acute respiratory syndromes
KR100715816B1 (ko) 2006-03-09 2007-05-08 부경대학교 산학협력단 가물치 피부 조직 유래 신경성 펩티드 및 그 유사체
US8538535B2 (en) 2010-08-05 2013-09-17 Rainbow Medical Ltd. Enhancing perfusion by contraction
US8626290B2 (en) 2008-01-31 2014-01-07 Enopace Biomedical Ltd. Acute myocardial infarction treatment by electrical stimulation of the thoracic aorta
US9005106B2 (en) * 2008-01-31 2015-04-14 Enopace Biomedical Ltd Intra-aortic electrical counterpulsation
US8626299B2 (en) * 2008-01-31 2014-01-07 Enopace Biomedical Ltd. Thoracic aorta and vagus nerve stimulation
KR101130283B1 (ko) 2009-07-22 2012-03-26 부경대학교 산학협력단 평활근 이완활성을 지닌 칼시토닌 관련 펩타이드
US8649863B2 (en) 2010-12-20 2014-02-11 Rainbow Medical Ltd. Pacemaker with no production
US8855783B2 (en) 2011-09-09 2014-10-07 Enopace Biomedical Ltd. Detector-based arterial stimulation
EP2872070B1 (en) 2011-09-09 2018-02-07 Enopace Biomedical Ltd. Wireless endovascular stent-based electrodes
US9386991B2 (en) 2012-02-02 2016-07-12 Rainbow Medical Ltd. Pressure-enhanced blood flow treatment
US10779965B2 (en) 2013-11-06 2020-09-22 Enopace Biomedical Ltd. Posts with compliant junctions
US11400299B1 (en) 2021-09-14 2022-08-02 Rainbow Medical Ltd. Flexible antenna for stimulator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380758A (en) * 1991-03-29 1995-01-10 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
IL101406A (en) * 1991-03-29 1998-02-08 Brigham & Womens Hospital Pharmaceutical compositions containing s-nitrosothiol derivatives
DK0676964T3 (da) * 1991-11-14 2001-02-05 Brigham & Womens Hospital Nitrosylering af enzym-SH-grupper som en terapeutisk modalitet
US5508045A (en) * 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
US5439938A (en) * 1993-04-07 1995-08-08 The Johns Hopkins University Treatments for male sexual dysfunction

Also Published As

Publication number Publication date
JPH11504008A (ja) 1999-04-06
EP0822826B1 (en) 2001-09-12
EP0822826A4 (enExample) 1998-02-25
CA2218616C (en) 2001-06-19
CA2218616A1 (en) 1996-10-24
US5612314A (en) 1997-03-18
DE69615171D1 (de) 2001-10-18
JP3915125B2 (ja) 2007-05-16
AU5446996A (en) 1996-11-07
WO1996032954A1 (en) 1996-10-24
EP0822826A1 (en) 1998-02-11

Similar Documents

Publication Publication Date Title
AU705533B2 (en) Nitrosylated neuropeptides
RU2492183C2 (ru) Пептид, фармацевтическая композиция (варианты) и лекарственное средство на его основе, способ лечения и/или предупреждения диабета или заболеваний, сопутствующих ожирению, способ уменьшения аппетита, уменьшения потребления пищи, уменьшения потребления калорий, уменьшения массы тела и увеличения расхода энергии
Himick et al. CCK/gastrin-like immunoreactivity in brain and gut, and CCK suppression of feeding in goldfish
TWI705973B (zh) Ｇｉｐ促效劑化合物及方法
JP5792925B2 (ja) 過剰体重を防止または治療するためのオキシンソモジュリン
US6307017B1 (en) Octapeptide bombesin analogs
BR112020026671A2 (pt) Compostos coagonistas de gip/glp1
PL193236B1 (pl) Zastosowania amyliny lub agonisty amyliny
CA2218173A1 (en) Analogs of growth hormone-releasing factor
EA034322B1 (ru) Ацилированные аналоги глюкагона
KR20150116912A (ko) 글루카곤 유사체
CN101203531A (zh) 修饰的pyy（3-36）多肽及它们对进食行为的影响
JP2008543816A (ja) 新規化合物および該化合物が摂食行動に及ぼす効果
WO1996040185A1 (en) Relaxin analogs and derivatives methods and uses thereof
PT1971362E (pt) Exendina para tratamento de diabetes e redução do peso corporal
JP2009280598A (ja) 胃腸管上部の機能を強化する方法
KR20120127610A (ko) 신규 화합물 및 식습관에 대한 이의 효과
CA3073011C (en) Acylated oxyntomodulin peptide analog
McKenzie et al. Pancreatic spasmolytic polypeptide protects the gastric mucosa but does not inhibit acid secretion or motility
JP2022504596A (ja) ヒトアミリンアナログペプチド及び使用方法
US5145837A (en) Treatment of arthritis
AU677324B2 (en) Motilin-like polypeptides with gastrointestinal motor stimulating activity
JP4372345B2 (ja) 新規な混合アミリン活性化合物
EP1752158A1 (en) Corneal neuritogenesis promoter containing pacap and its derivative
RU2839688C2 (ru) Полипептиды аналога амилина человека и способы их применения